rare disease

» Horizon Therapeutics and Massachusetts Institute of Technology (MIT) Solve Announce Second Annual Horizon MyPharma Editions Award

Posted on Wednesday April 20th, 2022 Horizon Therapeutics has just announced the kickoff of the second annual global innovation challenge, the Horizon Prize in partnership with MIT Solve. The Horizon Prize asks a unique question to encourage entrepreneurs and innovators around the world to be creative in solving a problem faced by more than 400 … Read more

Biopharm Solutions attracts 75 billion won pre-IPO investment

Biopharm Solutions (CEO Choi Yong-moon), a new drug development company for the central nervous system (CNS) and rare diseases, announced on the 22nd that it has successfully completed the pre-IPO investment of KRW 75 billion. This investment is in the form of a project fund managed by Hana Financial Investment, in which Hana Financial Investment, … Read more